0001209191-16-141765.txt : 20160916
0001209191-16-141765.hdr.sgml : 20160916
20160916152148
ACCESSION NUMBER: 0001209191-16-141765
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160914
FILED AS OF DATE: 20160916
DATE AS OF CHANGE: 20160916
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 161889263
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-09-14
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2016-09-14
4
M
0
6500
36.30
A
274725
D
Common Stock
2016-09-14
4
S
0
400
88.76
D
274325
D
Common Stock
2016-09-14
4
S
0
3500
89.80
D
270825
D
Common Stock
2016-09-14
4
S
0
200
90.27
D
270625
D
Common Stock
2016-09-14
4
S
0
700
96.20
D
269925
D
Common Stock
2016-09-14
4
S
0
1700
97.17
D
268225
D
Common Stock
13286
I
401(k)
Common Stock
78200
I
Common Stock Held In Trust
Stock Option (Right to Buy)
36.30
2016-09-14
4
M
0
6500
0.00
D
2017-01-23
Common Stock
6500
112000
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $88.76 (range $88.22 to $88.99).
Open market sales reported on this line occurred at a weighted average price of $89.80 (range $89.26 to $90.20).
Open market sales reported on this line occurred at a weighted average price of $90.27 (range $90.26 to $90.28).
Open market sales reported on this line occurred at a weighted average price of $96.20 (range $95.78 to $96.72).
Open market sales reported on this line occurred at a weighted average price of $97.17 (range $96.83 to $97.71).
Fully vested.
Omar White, Attorney-In-Fact
2016-09-16